The European Vulvovaginal Epidemiological Survey (EVES). Impact of history of breast cancer on prevalence, symptoms, sexual function and quality of life related to vulvovaginal atrophy

References

• Nappi RE, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric. 2014;17(1):3–9.
   PubMed Web of Science ®Google Scholar
• Kingsberg SA, Wysocki S, Magnus L, et al. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. J Sex Med. 2013;10(7):1790–1799.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes (VIVA) – results from an international survey. Climacteric. 2012;15(1):36–44.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Kokot-Kierepa M. Women's voices in the menopause: results from an international survey on vaginal atrophy. Maturitas. 2010;67(3):233–238.
   PubMed Web of Science ®Google Scholar
• Iosif CS, Bekassy Z. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand. 1984;63(3):257–260.
   PubMed Web of Science ®Google Scholar
• Stadberg E, Mattsson LA, Milsom I. The prevalence and severity of climacteric symptoms and the use of different treatment regimens in a Swedish population. Acta Obstet Gynecol Scand. 1997;76(5):442–448.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Palacios S, Panay N, et al. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Climacteric. 2016;19(2):188–197.
   PubMed Web of Science ®Google Scholar
• Levine KB, Williams RE, Hartmann KE. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause. 2008;15(4 Pt 1):661–666.
   PubMed Web of Science ®Google Scholar
• Biglia N, Bounous VE, Sgro LG, et al. Genitourinary syndrome of menopause in breast cancer survivors: are we facing new and safe hopes? Clin Breast Cancer. 2015;15(6):413–420.
   PubMed Web of Science ®Google Scholar
• Crandall C, Petersen L, Ganz PA, et al. Association of breast cancer and its therapy with menopause-related symptoms. Menopause N Y N. 2004;11(5):519–530.
   PubMed Web of Science ®Google Scholar
• Oyarzún MFG, Castelo-Branco C. Local hormone therapy for genitourinary syndrome of menopause in breast cancer patients: is it safe? Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2017;33(6):418–420.
   Google Scholar
• Ganz PA, Rowland JH, Desmond K, et al. Life after breast cancer: understanding women's health-related quality of life and sexual functioning . J Clin Oncol. 1998;16(2):501–514.
   PubMed Web of Science ®Google Scholar
• Biglia N, Cozzarella M, Cacciari F, et al. Menopause after breast cancer: a survey on breast cancer survivors. Maturitas. 2003;45(1):29–38.
   PubMed Web of Science ®Google Scholar
• Arraras JI, Illarramendi JJ, de la Cruz S, et al. Erratum: Quality of life in long-term premenopausal early-stage breast cancer survivors from Spain. Effects of surgery and time since surgery. J BUON Off J Balk Union Oncol. 2016;21(6):1573.
   PubMedGoogle Scholar
• Joly F, Espié M, Marty M, et al. Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy. Br J Cancer. 2000;83(5):577–582.
   PubMed Web of Science ®Google Scholar
• Lindley C, Vasa S, Sawyer WT, et al. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Cin Oncol. 1998;16(4):1380–1387.
   PubMed Web of Science ®Google Scholar
• Palacios S, Nappi RE, Bruyniks N, et al. EVES Study Investigators. The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause. Climacteric J Int Menopause Soc. 2018;21(3):286–286.
   PubMed Web of Science ®Google Scholar
• EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy Amst Neth. 1990;16(3):199–208.
   PubMed Web of Science ®Google Scholar
• Huang AJ, Gregorich SE, Kuppermann M, et al. Day-to-Day Impact of Vaginal Aging questionnaire: a multidimensional measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women. Menopause. 2015;22(2):144–154.
   PubMed Web of Science ®Google Scholar
• Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31(1):1–20.
   PubMed Web of Science ®Google Scholar
• Derogatis LR, Rosen R, Leiblum S, et al. The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther. 2002;28(4):317–330.
   PubMed Web of Science ®Google Scholar
• Bachmann G. Urogenital ageing: an old problem newly recognized. Maturitas. 1995;22(Suppl):S1–S5.
   PubMedGoogle Scholar
• Impact of Sample Size and Variability on the Power and Type I Error Rates of Equivalence Tests: A Simulation Study – Practical Assessment, Research & Evaluation – getvn.asp. [cited 2017 Nov 16]. Available from: http://pareonline.net/getvn.asp?v=19&n=11.
   Google Scholar
• Biglia N, Bounous VE, D’Alonzo M, et al. Vaginal atrophy in breast cancer survivors: attitude and approaches among oncologists. Clin Breast Cancer. 2017;17(8):611–617.
   PubMed Web of Science ®Google Scholar
• Lester J, Pahouja G, Andersen B, et al. Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue. J Pers Med. 2015;5(2):50–66.
   PubMed Web of Science ®Google Scholar
• Burgess C, Cornelius V, Love S, et al. Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ. 2005;330(7493):702.
   PubMed Web of Science ®Google Scholar
• Stafford L, Judd F, Gibson P, et al. Screening for depression and anxiety in women with breast and gynaecologic cancer: course and prevalence of morbidity over 12 months. Psychooncology. 2013;22(9):2071–2078.
   PubMed Web of Science ®Google Scholar
• Derogatis L, Clayton A, Lewis-D’Agostino D, et al. Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med. 2008;5(2):357–364.
   PubMed Web of Science ®Google Scholar
• Baumgart J, Nilsson K, Stavreus-Evers A, et al. Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer. Am J Obstet Gynecol. 2011;204(1):26.e1–26.e7.
   PubMed Web of Science ®Google Scholar
• Groenvold M. Health-related quality of life in early breast cancer. Dan Med Bull. 2010;57(9):B4184.
   PubMedGoogle Scholar